PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Nortem Biogroup ( XPAR:MLBIO ) from 2023 to Jun 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Nortem Biogroup stock (XPAR:MLBIO) PE ratio as of Jun 21 2024 is 27.84. More Details

Nortem Biogroup (XPAR:MLBIO) PE Ratio (TTM) Chart

To

Nortem Biogroup (XPAR:MLBIO) PE Ratio (TTM) Historical Data

Total 192
  • 1
  • 2
  • 3
Nortem Biogroup PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-21 27.8 2024-04-19 27.8
2024-06-20 27.8 2024-04-18 27.8
2024-06-19 27.8 2024-04-17 27.8
2024-06-18 27.8 2024-04-16 27.8
2024-06-17 27.8 2024-04-15 27.8
2024-06-14 27.8 2024-04-12 27.8
2024-06-13 27.8 2024-04-11 27.8
2024-06-12 27.8 2024-04-10 27.8
2024-06-11 27.8 2024-04-09 27.8
2024-06-10 27.8 2024-04-08 27.8
2024-06-07 27.8 2024-04-05 27.8
2024-06-06 27.8 2024-04-04 27.8
2024-06-05 27.8 2024-04-03 27.8
2024-06-04 27.8 2024-04-02 27.8
2024-06-03 27.8 2024-04-01 27.8
2024-05-31 27.8 2024-03-29 27.8
2024-05-30 27.8 2024-03-28 27.8
2024-05-29 27.8 2024-03-27 27.8
2024-05-28 27.8 2024-03-26 27.8
2024-05-27 27.8 2024-03-25 27.8
2024-05-24 27.8 2024-03-22 27.8
2024-05-23 27.8 2024-03-21 27.8
2024-05-22 27.8 2024-03-20 27.8
2024-05-21 27.8 2024-03-19 27.8
2024-05-20 27.8 2024-03-18 27.8
2024-05-17 27.8 2024-03-15 27.8
2024-05-16 27.8 2024-03-14 27.8
2024-05-15 27.8 2024-03-13 27.8
2024-05-14 27.8 2024-03-12 27.8
2024-05-13 27.8 2024-03-11 27.8
2024-05-10 27.8 2024-03-08 27.8
2024-05-09 27.8 2024-03-07 27.8
2024-05-08 27.8 2024-03-06 27.8
2024-05-07 27.8 2024-03-05 27.8
2024-05-06 27.8 2024-03-04 27.8
2024-05-03 27.8 2024-03-01 27.8
2024-05-02 27.8 2024-02-29 27.8
2024-05-01 27.8 2024-02-28 27.8
2024-04-30 27.8 2024-02-27 27.8
2024-04-29 27.8 2024-02-26 27.8
2024-04-26 27.8 2024-02-23 27.8
2024-04-25 27.8 2024-02-22 27.8
2024-04-24 27.8 2024-02-21 27.8
2024-04-23 27.8 2024-02-20 27.8
2024-04-22 27.8 2024-02-19 27.8

Nortem Biogroup (XPAR:MLBIO) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.